Longbio Pharma

This study tested a new drug called LP-003 for adults with moderate to severe seasonal allergies (hay fever) whose symptoms are not controlled by standard treatments like nasal sprays and allergy pills. Over 12 weeks, researchers compared LP-003 to a placebo to see if it better r…

This was the first study in humans to test the safety and basic behavior of a new drug called LP-005. It involved 68 healthy volunteers to see how their bodies handled single and multiple doses. The drug is being developed to treat a rare blood disorder called Paroxysmal Nocturna…

This study tested an investigational injection called LP-003 for adults with chronic spontaneous urticaria (CSU), a condition causing long-lasting, itchy hives. It was for people whose hives and itching were not controlled even with standard or higher doses of common antihistamin…

This was the first study in humans to test a potential new drug called LP-003, which is being developed for chronic hives. Researchers gave single and then multiple doses to 60 healthy volunteers to check if it was safe and to see how the body processes it. The main goal was to u…

This was an early-stage study to check the safety and see how the body handles a new drug called LP-001. It involved 68 healthy volunteers and tested single and multiple doses. The main goal was to see what side effects might occur and to measure how long the drug stays in the bl…